Previous 10 | Next 10 |
2024-01-22 11:29:07 ET More on S&P 500 Index: S&P 500 Sets New Record High As Investors Potentially Shift Focus To Q2 2024 Market Rally Met With Outflows S&P 500: The 'Pump' Is Underway - Watch Out For The 'Dump' S&P won't get the helping hand...
2024-01-22 07:51:11 ET More on Natera, Invitae, etc. Stocks To Watch: Energy Market Drama And Financial Earnings Headline Holiday Week Natera: Squeezing The Last Drop From NIPT Growth Engine Invitae Corporation 2023 Q3 - Results - Earnings Call Presentation C...
Invitae Completes Sale of Reproductive Health Assets to Natera PR Newswire SAN FRANCISCO , Jan. 22, 2024 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced it has completed the sale of certain reproductive health as...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA (cfDNA) testing, today announced that it has acquired from Invitae (NYSE: NVTA), a leading medical genetics company, certain assets relating to Invitae’s non-invasive prenatal screening and carrier screening business. Nate...
Oral presentations include updated 24-month DFS analysis from GALAXY and first interim analysis from BESPOKE CRC Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that new data on its personalized and tumor-informed molecular residual disease (MR...
2024-01-17 21:22:40 ET Summary Shares of Oxford Nanopore declined by 33% after slower than expected growth in the second half of 2023. Positive outlook on the company, but profitability not expected until 2026. Challenging market with slow adoption of new technology, but new p...
2024-01-17 15:51:07 ET More on Natera Natera: Squeezing The Last Drop From NIPT Growth Engine Natera, Inc. (NTRA) Q3 2023 Earnings Call Transcript Natera, Inc. 2023 Q3 - Results - Earnings Call Presentation Piper says RavGen decision largely removes legal ove...
2024-01-17 14:27:40 ET More on Natera Natera: Squeezing The Last Drop From NIPT Growth Engine Natera, Inc. (NTRA) Q3 2023 Earnings Call Transcript Natera, Inc. 2023 Q3 - Results - Earnings Call Presentation Natera says jury reached verdict of no willful infri...
2024-01-17 09:23:00 ET U.S. stock index futures on Wednesday were in the red, as some concerns over the trajectory of anticipated interest rate cuts from the previous session continued to weigh on sentiment. Moreover, retail sales data came in hotter-than-expected. Here are some stocks to w...
2024-01-16 17:30:34 ET More on Natera Natera: Squeezing The Last Drop From NIPT Growth Engine Natera, Inc. (NTRA) Q3 2023 Earnings Call Transcript Natera, Inc. 2023 Q3 - Results - Earnings Call Presentation Natera raises FY23 revenue guidance by $20M to $1.07...
News, Short Squeeze, Breakout and More Instantly...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that members of its leadership team will present at the Canaccord Genuity 44th Annual Growth Conference on Wednesday, Aug. 14 at 12:30 pm ET | 9:30 am PT in Boston, MA. A live webcast and audio archive of...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will release results for its second quarter ended June 30, 2024, after the market close on Aug. 8, 2024. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET...
Study reports high accuracy of Signatera for surveillance of MCC patients, suggests potential to reduce frequency of surveillance imaging Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced a new study published in the Journal of Clinical Oncolog...